Trials / Not Yet Recruiting
Not Yet RecruitingNCT05730595
Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
A Randomized Controlled Trial of Fluorescence Laparoscopic Navigation of the Extent of Lymph Node Dissection for High Rectal Cancer and Sigmoid Colon Cancer
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 550 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To explore the short-term and long-term outcomes of fluorescence laparoscopic navigation D2 lymph node dissection for colorectal cancer surgery by comparing it with D3 lymph node dissection.
Detailed description
Lymph node metastasis is the most common metastatic mechanisms for colorectal cancer. Therefore, regional lymph node dissection is the key part in radical surgery for colorectal cancer. In patients who have developed lymph node metastases, inadequate lymph node dissection will promote tumor recurrence. In patients who do not develop lymph node metastases, excessive lymph node dissection not only does not improve the patient's prognosis, but also increases surgical trauma and destroys the antitumor effect of the lymphoid immune system. There is still some controversy over whether to choose D3 lymph node dissection or D2 lymph node dissection for rectal and sigmoid cancer. Fluorescence laparoscopic navigation techniques can guide lymph node dissection by visualizing lymph nodes more clearly during surgery. This study will compare the short-term and long-term oncological outcomes between fluorescence laparoscopic navigation D2 and D3 lymph node dissection by conducting a randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | lymph node dissection | The extent of lymph node dissection varies between groups |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2026-12-01
- Completion
- 2027-06-01
- First posted
- 2023-02-16
- Last updated
- 2023-08-29
Locations
19 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05730595. Inclusion in this directory is not an endorsement.